Carrier Screening Associated With Decrease in Incidence of Cystic Fibrosis
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Carrier Screening Associated With Decrease in Incidence of Cystic Fibrosis

CHICAGO -- December 15, 2009 -- An increase in the number of screened carriers for cystic fibrosis (CF) was associated with a decrease in the number of children born with CF in northeast Italy, according to a study published in the December 16 issue of JAMA.

Some studies have suggested that there has been a progressive decrease in the incidence of newborns with CF in some areas. “A circumstance that might influence CF birth rates is the detection of carrier couples,” the authors wrote.

Carlo Castellani, MD, Cystic Fibrosis Center, Verona Hospital, Verona, Italy, and colleagues evaluated the association between CF carrier screening and CF birth incidence in northeastern Italy, where CF neonatal screening has been performed for many years.

Since the early 1990s, a significant progressive decrease of CF birth rates has been recorded for this area. In this region, 2 different carrier detection approaches were identified -- the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilisation; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age.

A total of 779,631 newborns underwent CF neonatal screening between January 1993 and December 2007, of whom 195 had CF detected.

During the study period, a time-related decrease in CF birth incidence was found, with an average annual percentage decrease of 0.16 per 10,000 neonates. The rate of decrease was greater in the eastern region (0.24 per 10,000) than the western region (0.04 per 10,000). In the western region, 2,559 carrier tests were performed; 314 carriers and 9 carrier couples were detected. In the eastern region, 87,025 carrier tests were performed; 3,650 carriers and 82 carrier couples were detected. Carrier rate (number of carriers/number of tests) was 1/8.1 in the western region and 1/23.8 in the eastern region.

“Although CF birth incidence decreased over time in the whole area under study, the number of new CF cases identified each year decreased only slightly in the western region, with its limited carrier testing, and decreased significantly in the eastern region, with its intensive screening of couples of reproductive age,” the authors wrote.

“The overall negative trend in northeastern Italy is mainly due to a reduction of CF births in the eastern region. The reduction appears to be connected with the extensive use of mutation analysis in the general population -- as the number of individuals screened with the CF carrier test progressively increased, CF birth incidence gradually and constantly decreased.”

SOURCE: JAMA

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities